Gritstone bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 1.96 million compared to USD 5.47 million a year ago. Net loss was USD 35.26 million compared to USD 29.52 million a year ago. Basic loss per share from continuing operations was USD 0.31 compared to USD 0.34 a year ago.
For the six months, revenue was USD 4.4 million compared to USD 12.66 million a year ago. Net loss was USD 69.24 million compared to USD 58.43 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 0.68 a year ago.